Summary
But for the U.S. pharmaceutical company which shelved its planned facility meant to support early-stage life sciences businesses with lab space, mentorship and potential financial backing the proposal alone is not enough.
I dont think we have heard enough to say that we are willing to get the…
Source: politico.eu
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
